Feed PRMD.ME
PR
iPROMOMED
PRMD.ME · MCX
364.55 ₽ -1.62% (-6.00 ₽)
1M +11.71%
Market Cap 79.0B ₽
P/E Ratio 27.29x
Div. Yield -
ROE -
Valuation
50 /100
Fair P/S 3.68x
P/E 27.29x
P/B 4.08x
Growth
43 /100
Stable Book val. growth 26.69%
EPS growth 21.73%
Rev. growth 9.42%
Profitability
66 /100
Moderate Op. margin 32.15%
Gross margin 66.21%
FCF margin 18.51%
Quality
50 /100
Average Asset turnover 0.40x
ROIC 9.86%
ROA 5.45%
Debt
57 /100
Moderate Int. coverage 2.79x
Debt/Equity 1.09x
Net debt/EBITDA 2.12x
Stability
77 /100
Stable EPS volatility 14.48%
Beta 0.56x
Profitable years 4
Întreabă StockBot despre PRMD.ME
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Nimesh Shah
Employees
2,000
Headquarters
-